Open Thread 427
Summary
This weekly open thread from ACX provides several updates, including a job opening and a fellowship program. ACX Grantee 1DaySooner is seeking a remote Policy Lead for Clinical Trial Abundance, offering a salary of $100K - $145K. Newspeak House in London is accepting applications for its 2026 "Introduction to Political Technology" fellowship, an immersive year-long program for mid-career technologists. The author also addresses reader feedback on a previous post, "Every Debate On Pausing AI," clarifying that the "Every" in the title was intended humorously and acknowledging valid objections to AI pauses. A new subscriber-only post reviews "The White King Of La Gonave," an autobiography about a US Marine who became a Caribbean island king. The author will be away for several weeks on a journalistic mission, leading to less timely posts and reduced comment engagement.
Key takeaway
For Directors of AI/ML evaluating policy implications, note the ongoing debate around AI pauses and the emergence of detailed plans like the one cited. Your teams should consider engaging with these proposals to understand potential regulatory landscapes. Additionally, if you are a mid-career technologist, the Newspeak House fellowship offers a unique opportunity to integrate into the political technology landscape, potentially shaping future projects or strategic roles.
Key insights
The post offers community updates, job opportunities, and clarifies previous content, alongside a new book review.
Principles
- Humor in titles can be misinterpreted.
- Community feedback refines communication.
In practice
- Explore the 1DaySooner Policy Lead role.
- Consider the Newspeak House fellowship.
- Review the "White King Of La Gonave" book.
Topics
- Clinical Trial Abundance
- Policy Lead Role
- Political Technology Fellowship
- AI Pause Debate
- AI Policy
Best for: Policy Maker, AI Ethicist, Director of AI/ML
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by Astral Codex Ten.